UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intracerebral hemorrhage after external ventricular drain placement: an evaluation of risk factors for post-procedural hemorrhagic complications

BMC neurology, 2018-03, Vol.18 (1), p.22-22, Article 22

2018

Volltextzugriff (PDF)

Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit

Journal of critical care, 2015-12, Vol.30 (6), p.1283-1286

2015

Volltextzugriff (PDF)

Assessment of Clinical Pharmacy Interventions to Reduce Outpatient Use of High-Risk Medications in the Elderly

Journal of managed care & specialty pharmacy, 2017-05, Vol.23 (5), p.520-524

2017

Volltextzugriff (PDF)

The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement: A Statement for Healthcare Professionals from the Neurocritical Care Society

Neurocritical care, 2016-02, Vol.24 (1), p.61-81

2016

Volltextzugriff (PDF)

Key Articles and Guidelines in the Primary Prevention of Ischemic Stroke

Pharmacotherapy, 2013-06, Vol.33 (6), p.e101-e114

2013

Volltextzugriff (PDF)

Pharmacy Student Knowledge Retention After Completing Either a Simulated or Written Patient Case

American journal of pharmaceutical education, 2012-06, Vol.76 (5), p.86, Article 86

2012

Volltextzugriff (PDF)

Low Dose Aspirin Initiation 18 Hours After Thrombolytic Therapy in Acute Ischemic Stroke

The Neurologist (Baltimore, Md.), 2024-09, Vol.29 (5), p.294-298

2024

Volltextzugriff (PDF)

540: IMPACT OF OBESITY ON WARFARIN REVERSAL WITH FIXED-DOSE FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY

Critical care medicine, 2020-01, Vol.48 (1), p.251-251

2020

Volltextzugriff (PDF)

Predictive value of methicillin-resistant staphylococcus aureus nasal swab in patients with COVID-19 pneumonia and secondary bacterial pneumonia

Diagnostic microbiology and infectious disease, 2024-02, Vol.108 (2), p.116134-116134, Article 116134

2024

Volltextzugriff (PDF)

A Study of the MTHFR Gene Prevalence in a Rural Tennessee Opioid Use Disorder Treatment Center Population

International journal of environmental research and public health, 2022-03, Vol.19 (6), p.3255

2022

Volltextzugriff (PDF)

Incidence of Hypertriglyceridemia in Patients on Propofol, Clevidipine, or Both

The Annals of pharmacotherapy, 2024-12, Vol.58 (12), p.1187-1192

2024

Volltextzugriff (PDF)

Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury

The Annals of pharmacotherapy, 2014-11, Vol.48 (11), p.1440-1444

2014

Volltextzugriff (PDF)

756: IDENTIFICATION OF RISK FACTORS FOR REFRACTORY STATUS EPILEPTICUS

Critical care medicine, 2019-01, Vol.47 (1), p.357-357

2019

Volltextzugriff (PDF)

INR Response to Low-Dose Vitamin K in Warfarin Patients

The Annals of pharmacotherapy, 2021-10, Vol.55 (10), p.1223-1229

2021

Volltextzugriff (PDF)

23.4% Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure in Patients With Traumatic Brain Injury: A Single-Center Retrospective Cohort Study

The Annals of pharmacotherapy, 2021-08, Vol.55 (8), p.988-994

2021

Volltextzugriff (PDF)

Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke

The Annals of pharmacotherapy, 2023-05, Vol.57 (5), p.535-543

2023

Volltextzugriff (PDF)

Impact of Obesity on Warfarin Reversal With Fixed-Dose Factor VIII Inhibitor Bypassing Activity (aPCC)

The Annals of pharmacotherapy, 2021-07, Vol.55 (7), p.856-862

2021

Volltextzugriff (PDF)

Identification of Risk Factors for Refractory Status Epilepticus

The Annals of pharmacotherapy, 2020-01, Vol.54 (1), p.14-21

2020

Volltextzugriff (PDF)

Thromboelastographic Changes in Patients Experiencing an Acute Ischemic Stroke and Receiving Alteplase

Journal of stroke and cerebrovascular diseases, 2014-07, Vol.23 (6), p.1307-1311

2014

Volltextzugriff (PDF)

Theophylline for Spinal Cord Injury Associated Bradycardia

Journal of pharmacy practice, 2023-06, Vol.36 (3), p.579-583

2023

Volltextzugriff (PDF)

Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage

American journal of health-system pharmacy, 2010-03, Vol.67 (5), p.361-365

2010

Volltextzugriff (PDF)

Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal

Critical care medicine, 2018-06, Vol.46 (6), p.943-948

2018

Volltextzugriff (PDF)

Efficacy of Cefazolin versus Ceftriaxone for Extremity Open Fracture Management at a Level 1 Trauma Center

Surgical infections, 2022-09, Vol.23 (7), p.675-681

2022

Volltextzugriff (PDF)

Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients

Journal of thrombosis and thrombolysis, 2022-05, Vol.53 (4), p.861-867

2022

Volltextzugriff (PDF)

Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries

Neurocritical care, 2022-10, Vol.37 (2), p.471-478

2022

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Intracerebral hemorrhage after external ventricular drain placement: an evaluation of risk factors for post-procedural hemorrhagic complications

Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit

Assessment of Clinical Pharmacy Interventions to Reduce Outpatient Use of High-Risk Medications in the Elderly

The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement: A Statement for Healthcare Professionals from the Neurocritical Care Society

Key Articles and Guidelines in the Primary Prevention of Ischemic Stroke

Pharmacy Student Knowledge Retention After Completing Either a Simulated or Written Patient Case

Low Dose Aspirin Initiation 18 Hours After Thrombolytic Therapy in Acute Ischemic Stroke

540: IMPACT OF OBESITY ON WARFARIN REVERSAL WITH FIXED-DOSE FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY

Predictive value of methicillin-resistant staphylococcus aureus nasal swab in patients with COVID-19 pneumonia and secondary bacterial pneumonia

A Study of the MTHFR Gene Prevalence in a Rural Tennessee Opioid Use Disorder Treatment Center Population

Incidence of Hypertriglyceridemia in Patients on Propofol, Clevidipine, or Both

Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury

756: IDENTIFICATION OF RISK FACTORS FOR REFRACTORY STATUS EPILEPTICUS

INR Response to Low-Dose Vitamin K in Warfarin Patients

23.4% Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure in Patients With Traumatic Brain Injury: A Single-Center Retrospective Cohort Study

Major Bleeding Postadministration of Tenecteplase Versus Alteplase in Acute Ischemic Stroke

Impact of Obesity on Warfarin Reversal With Fixed-Dose Factor VIII Inhibitor Bypassing Activity (aPCC)

Identification of Risk Factors for Refractory Status Epilepticus

Thromboelastographic Changes in Patients Experiencing an Acute Ischemic Stroke and Receiving Alteplase

Theophylline for Spinal Cord Injury Associated Bradycardia

Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage

Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal

Efficacy of Cefazolin versus Ceftriaxone for Extremity Open Fracture Management at a Level 1 Trauma Center

Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients

Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries

Suchergebnisse filtern